CMS announced Thursday (Nov. 20) plans to finalize the Medicaid Average Manufacturer Price-based Federal Upper Limits around the same time it releases the Medicaid Covered Outpatient Drug final rule. The agency says it will also release detailed guidance to the states on how to implement the Affordable Care Act FULs at the same time. The agency is required by the ACA to recalculate the FUL amounts, as they sometimes exceeded the market prices for multiple-source drugs. Late last year, CMS...